<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>Libby&#039;s H*O*P*E*</title>
	<atom:link href="http://healthinfoispower.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://healthinfoispower.wordpress.com</link>
	<description>*Helping*Ovarian Cancer Survivors*Persevere Through*Education</description>
	<lastBuildDate>Wed, 25 Jan 2012 14:49:40 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='healthinfoispower.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://0.gravatar.com/blavatar/e45e223349a1a9906dc639d47d41ea4c?s=96&#038;d=http%3A%2F%2Fs2.wp.com%2Fi%2Fbuttonw-com.png</url>
		<title>Libby&#039;s H*O*P*E*</title>
		<link>http://healthinfoispower.wordpress.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://healthinfoispower.wordpress.com/osd.xml" title="Libby&#039;s H*O*P*E*" />
	<atom:link rel='hub' href='http://healthinfoispower.wordpress.com/?pushpress=hub'/>
		<item>
		<title>Small Study Finds Tumor-Freezing Cryoablation Treatment Extends Survival of Select Metastatic Ovarian Cancer Patients</title>
		<link>http://healthinfoispower.wordpress.com/2012/01/16/small-study-finds-tumor-freezing-cryoablation-treatment-extends-survival-of-select-metastatic-ovarian-cancer-patients/</link>
		<comments>http://healthinfoispower.wordpress.com/2012/01/16/small-study-finds-tumor-freezing-cryoablation-treatment-extends-survival-of-select-metastatic-ovarian-cancer-patients/#comments</comments>
		<pubDate>Mon, 16 Jan 2012 21:24:11 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Medical Study Results]]></category>
		<category><![CDATA[Meeting Highlights]]></category>
		<category><![CDATA[Novel Therapies]]></category>
		<category><![CDATA[2012 Clinical Interventional Oncology Symposium]]></category>
		<category><![CDATA[2012 International Symposium on Endovascular Therapy]]></category>
		<category><![CDATA[cryoablation]]></category>
		<category><![CDATA[Detroit Medical Center]]></category>
		<category><![CDATA[Hyun J. Bang M.D.]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Wayne State University]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7672</guid>
		<description><![CDATA[A small study of 21 ovarian cancer patients reported that killing tumors by freezing them through cryoablation can extend the lives of select women with metastatic disease which has spread to the abdomen, liver, lung or bone, and can not be removed surgically. From the time of diagnosis of metastatic disease, the average patient survival time [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7672&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2012/01/16/small-study-finds-tumor-freezing-cryoablation-treatment-extends-survival-of-select-metastatic-ovarian-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2012/01/cryoablation.jpg" medium="image">
			<media:title type="html">Cryoablation</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2012/01/bang-hyun-j1.jpeg?w=200" medium="image">
			<media:title type="html">Bang, Hyun J.</media:title>
		</media:content>
	</item>
		<item>
		<title>Canadian Researchers Link DICER1 Gene Mutation to Non-Epithelial Ovarian Cancers &amp; Other Rare Tumor Types</title>
		<link>http://healthinfoispower.wordpress.com/2011/12/21/canadian-researchers-link-dicer1-gene-mutation-to-rare-non-epithelial-ovarian-cancers/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/12/21/canadian-researchers-link-dicer1-gene-mutation-to-rare-non-epithelial-ovarian-cancers/#comments</comments>
		<pubDate>Thu, 22 Dec 2011 05:47:53 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Discoveries]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Ovarian Cancer Studies]]></category>
		<category><![CDATA[Preclinical Testing]]></category>
		<category><![CDATA[Andrew Fire Ph.D.]]></category>
		<category><![CDATA[British Columbia Cancer Agency]]></category>
		<category><![CDATA[Craig C. Mello Ph.D.]]></category>
		<category><![CDATA[David Huntsman M.D.]]></category>
		<category><![CDATA[DICER RNase IIIb domain]]></category>
		<category><![CDATA[DICER1]]></category>
		<category><![CDATA[germ cell ovarian cancer]]></category>
		<category><![CDATA[germ cell yolk sac type tumor]]></category>
		<category><![CDATA[granulosa cell tumor]]></category>
		<category><![CDATA[Gregg Morin Ph.D.]]></category>
		<category><![CDATA[M.D. Anderson Cancer Center]]></category>
		<category><![CDATA[messenger RNA]]></category>
		<category><![CDATA[Michael Smith Genome Sciences Centre]]></category>
		<category><![CDATA[microRNA]]></category>
		<category><![CDATA[Nobel Prize in Physiology or Medicine]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Phillip A. Sharp Ph.D.]]></category>
		<category><![CDATA[rhabdomyosarcomas]]></category>
		<category><![CDATA[RNA interference]]></category>
		<category><![CDATA[RNAi]]></category>
		<category><![CDATA[Sertoli-Leydig ovarian cancer]]></category>
		<category><![CDATA[sex cord-stromal ovarian cancer]]></category>
		<category><![CDATA[small interfering RNA]]></category>
		<category><![CDATA[somatic gene mutation]]></category>
		<category><![CDATA[testicular cancer]]></category>
		<category><![CDATA[transposons]]></category>
		<category><![CDATA[Univ. of British Columbia]]></category>
		<category><![CDATA[Vancouver Coastal Health Research Institute]]></category>
		<category><![CDATA[Vancouver General Hospital]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7606</guid>
		<description><![CDATA[Canadian researchers affiliated with the Ovarian Cancer Research Program of British Columbia report that recurrent, lifetime-acquired mutations affecting the DICER1 gene occur in a range of nonepithelial ovarian tumors as well as other rare cancer tumor types, and appear common in Sertoli-Leydig ovarian tumors. The study findings were published online today in the New England Journal [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7606&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/12/21/canadian-researchers-link-dicer1-gene-mutation-to-rare-non-epithelial-ovarian-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/12/morin.jpg?w=225" medium="image">
			<media:title type="html">Morin</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/12/huntsman1.jpg" medium="image">
			<media:title type="html">Dr. David Huntsman</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/12/sharp.jpg?w=278" medium="image">
			<media:title type="html">sharp</media:title>
		</media:content>
	</item>
		<item>
		<title>An Attitude of Gratitude On Thanksgiving Day</title>
		<link>http://healthinfoispower.wordpress.com/2011/11/24/an-attitude-of-gratitude-on-thanksgiving-day/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/11/24/an-attitude-of-gratitude-on-thanksgiving-day/#comments</comments>
		<pubDate>Thu, 24 Nov 2011 19:51:03 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[Humor]]></category>
		<category><![CDATA[Inspirational]]></category>
		<category><![CDATA[WORD of HOPE]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[President Abraham Lincoln]]></category>
		<category><![CDATA[President Barack Obama]]></category>
		<category><![CDATA[Thanksgiving 2011]]></category>
		<category><![CDATA[World Health Organization]]></category>
		<category><![CDATA[world poverty statistics]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7529</guid>
		<description><![CDATA[&#8220;Gratitude unlocks the fullness of life. It turns what we have into enough, and more. It turns denial into acceptance, chaos to order, confusion to clarity. It can turn a meal into a feast, a house into a home, a stranger into a friend. Gratitude makes sense of our past, brings peace for today, and [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7529&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/11/24/an-attitude-of-gratitude-on-thanksgiving-day/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/11/thanksgiving-clip-art.jpg" medium="image">
			<media:title type="html">thanksgiving clip art</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/11/beef_tnb.png?w=300" medium="image">
			<media:title type="html">Beef_tnb</media:title>
		</media:content>
	</item>
		<item>
		<title>FDA Revokes Approval of Avastin Use For Metastatic Breast Cancer; Major U.S. Ovarian Cancer Advocacy Organization Concerned</title>
		<link>http://healthinfoispower.wordpress.com/2011/11/18/fda-revokes-approval-of-avastin-use-for-metastatic-breast-cancer-major-u-s-ovarian-cancer-advocacy-organization-concerned/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/11/18/fda-revokes-approval-of-avastin-use-for-metastatic-breast-cancer-major-u-s-ovarian-cancer-advocacy-organization-concerned/#comments</comments>
		<pubDate>Sat, 19 Nov 2011 02:43:10 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Pipeline Drugs]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Avastin]]></category>
		<category><![CDATA[bevacizumab]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Centers for Medicare & Medicaid Services]]></category>
		<category><![CDATA[FDA Center For Drug Eval. & Res.]]></category>
		<category><![CDATA[FDA Fast Track Development Program]]></category>
		<category><![CDATA[FDA Oncologic Drugs Advisory Committee]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[Genentech]]></category>
		<category><![CDATA[Hal Barron M.D.]]></category>
		<category><![CDATA[Karen Orloff Kaplan]]></category>
		<category><![CDATA[Margaret A. Hamburg M.D.]]></category>
		<category><![CDATA[national comprehensive cancer network]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Ovarian Cancer National Alliance]]></category>
		<category><![CDATA[paclitaxel]]></category>
		<category><![CDATA[Roche Group]]></category>
		<category><![CDATA[Taxol]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7489</guid>
		<description><![CDATA[Today, the U.S. Food and Drug Administration (FDA) Commissioner Hamburg revoked approval of Avastin for treatment of metastatic breast cancer in the U.S. The decision does not impact Avastin&#8217;s availability for its approved uses for other cancer types in the U.S. A major U.S. ovarian cancer advocacy organization is concerned that the FDA decision will make [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7489&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/11/18/fda-revokes-approval-of-avastin-use-for-metastatic-breast-cancer-major-u-s-ovarian-cancer-advocacy-organization-concerned/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/11/fdalogo.jpg" medium="image">
			<media:title type="html">fdalogo</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/11/genentech.jpg" medium="image">
			<media:title type="html">Genentech</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/11/orloff-kaplan.jpg" medium="image">
			<media:title type="html">Orloff Kaplan</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/11/ocnalogo.jpg?w=300" medium="image">
			<media:title type="html">OCNAlogo</media:title>
		</media:content>
	</item>
		<item>
		<title>Ovarian Cancer Tumors Can Grow For Ten Years Or More Before Being Detected By Today&#8217;s Blood Tests</title>
		<link>http://healthinfoispower.wordpress.com/2011/11/18/ovarian-cancer-tumors-can-grow-for-ten-years-or-more-before-being-detected-by-todays-blood-tests/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/11/18/ovarian-cancer-tumors-can-grow-for-ten-years-or-more-before-being-detected-by-todays-blood-tests/#comments</comments>
		<pubDate>Fri, 18 Nov 2011 19:12:58 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Biomarker]]></category>
		<category><![CDATA[Early Detection]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[CA-125]]></category>
		<category><![CDATA[Canary Ctr. for Cancer Early Detection]]></category>
		<category><![CDATA[Canary Foundation]]></category>
		<category><![CDATA[Mathematical model]]></category>
		<category><![CDATA[NCI]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Patrick Brown M.D. Ph.D.]]></category>
		<category><![CDATA[PSA]]></category>
		<category><![CDATA[Sanjiv Gambhir M.D. Ph.D.]]></category>
		<category><![CDATA[Sharon Hori Ph.D.]]></category>
		<category><![CDATA[Stanford Cancer Institute]]></category>
		<category><![CDATA[Stanford University School of Medicine]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7467</guid>
		<description><![CDATA[A new mathematical model developed by Stanford University School of Medicine scientists finds that ovarian cancer tumors can grow for 10 years or longer before currently available blood tests will detect them. A new mathematical model developed by Stanford University School of Medicine scientists indicates that tumors can grow for 10 years or longer before currently available [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7467&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/11/18/ovarian-cancer-tumors-can-grow-for-ten-years-or-more-before-being-detected-by-todays-blood-tests/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/11/gambhir.jpg" medium="image">
			<media:title type="html">Dr. Sam Gambhir, M.D., Ph.D.</media:title>
		</media:content>
	</item>
		<item>
		<title>U.S. President Barack Obama Proclaims September 2011 As National Ovarian Cancer Awareness Month &#8212; What Should You Know?</title>
		<link>http://healthinfoispower.wordpress.com/2011/09/01/u-s-president-barack-obama-proclaims-september-2011-as-national-ovarian-cancer-awareness-month-what-should-you-know/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/09/01/u-s-president-barack-obama-proclaims-september-2011-as-national-ovarian-cancer-awareness-month-what-should-you-know/#comments</comments>
		<pubDate>Thu, 01 Sep 2011 23:03:15 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[Early Detection]]></category>
		<category><![CDATA[American Cancer Society]]></category>
		<category><![CDATA[BEAT ovarian cancer]]></category>
		<category><![CDATA[early warning signs & symptoms]]></category>
		<category><![CDATA[Gynecologic Cancer Foundation]]></category>
		<category><![CDATA[Libby's H*O*P*E*]]></category>
		<category><![CDATA[National Ovarian Cancer Awareness Month]]></category>
		<category><![CDATA[President Barack Obama]]></category>
		<category><![CDATA[Presidential Proclamation]]></category>
		<category><![CDATA[Society of Gynecologic Oncology]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7413</guid>
		<description><![CDATA[Today, U.S. President Barack Obama designated September 2010 as National Ovarian Cancer Awareness Month. During National Ovarian Cancer Awareness Month, Libby&#8217;s H*O*P*E*™ will honor the women who have lost their lives to the disease, support those who are currently battling the disease, and celebrate with those who have beaten the disease.  Today, U.S. President Barack [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7413&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/09/01/u-s-president-barack-obama-proclaims-september-2011-as-national-ovarian-cancer-awareness-month-what-should-you-know/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/09/whitehouseseal.jpg" medium="image">
			<media:title type="html">whitehouseseal</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/beatlogo_308x1962.jpg?w=300" medium="image">
			<media:title type="html">beatlogo_308x196</media:title>
		</media:content>
	</item>
		<item>
		<title>NOCC to Host Annual &#8220;Walk To Break The Silence On Ovarian Cancer&#8221; in the Greater Washington, D.C. Area</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/31/nocc-to-host-annual-walk-to-break-the-silence-on-ovarian-cancer-in-the-greater-washington-d-c-area/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/31/nocc-to-host-annual-walk-to-break-the-silence-on-ovarian-cancer-in-the-greater-washington-d-c-area/#comments</comments>
		<pubDate>Wed, 31 Aug 2011 23:16:36 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[Fund-Rasing Event]]></category>
		<category><![CDATA[Annapolis Maryland]]></category>
		<category><![CDATA[Nancy Long]]></category>
		<category><![CDATA[National Ovarian Cancer Coalition MD Chapter]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Ovarian Cancer Awareness Month]]></category>
		<category><![CDATA[Paula Kozik]]></category>
		<category><![CDATA[Quiet Waters Park]]></category>
		<category><![CDATA[Walk To Break the Silence On Ovarian Cancer]]></category>
		<category><![CDATA[Washington D.C.]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7387</guid>
		<description><![CDATA[The National Ovarian Cancer Coalition (NOCC) Central Maryland Chapter announces its annual “Walk to Break the Silence on Ovarian Cancer” to be held on Sunday, September 18, 2011 at Quiet Waters Park, located in Annapolis, Maryland. The National Ovarian Cancer Coalition (NOCC) Central Maryland Chapter announces its 2nd Annual “Walk to Break the Silence on Ovarian Cancer” to be [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7387&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/31/nocc-to-host-annual-walk-to-break-the-silence-on-ovarian-cancer-in-the-greater-washington-d-c-area/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/nocc-logo2.jpg?w=300" medium="image">
			<media:title type="html">NOCC-logo2</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2010/08/quietwaters_southriver_gazebo.jpg?w=300" medium="image">
			<media:title type="html">quietwaters_southriver_gazebo</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2010/08/quietwaterspark.jpg" medium="image">
			<media:title type="html">quietwaterspark</media:title>
		</media:content>
	</item>
		<item>
		<title>30-Day Mortality Associated With Primary Cytoreductive Surgery In Elderly Advanced Ovarian Cancer Patients Much Higher Than Previously Reported</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/24/30-day-mortality-associated-with-primary-cytoreductive-surgery-in-elderly-advanced-ovarian-cancer-patients-much-higher-than-previously-reported/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/24/30-day-mortality-associated-with-primary-cytoreductive-surgery-in-elderly-advanced-ovarian-cancer-patients-much-higher-than-previously-reported/#comments</comments>
		<pubDate>Thu, 25 Aug 2011 00:28:52 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Medical Study Results]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[cytoreductive surgery]]></category>
		<category><![CDATA[elderly patients]]></category>
		<category><![CDATA[Marsha Rivkin Center for Ovarian Cancer Research]]></category>
		<category><![CDATA[Melissa M. Thrall M.D.]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[post-surgical mortality]]></category>
		<category><![CDATA[SEER data]]></category>
		<category><![CDATA[University of Washington School of Medicine]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7356</guid>
		<description><![CDATA[Researchers affiliated with the University of Washington have determined that the 30-day mortality rate associated with primary cytoreductive surgery in elderly patients with advanced ovarian cancer is much higher than previously reported. Researchers affiliated with the University of Washington have determined that the 30-day mortality rate associated with primary cytoreductive surgery in elderly patients with [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7356&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/24/30-day-mortality-associated-with-primary-cytoreductive-surgery-in-elderly-advanced-ovarian-cancer-patients-much-higher-than-previously-reported/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/thrall-melissa.jpg" medium="image">
			<media:title type="html">Melissa Thrall, M.D.</media:title>
		</media:content>
	</item>
		<item>
		<title>PARP Inhibitor Olaparib Has Activity in High-Grade Serous Ovarian Cancer Without Inherited BRCA1 or BRCA2 Gene Mutations</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/22/parp-inhibitor-olaparib-has-activity-in-high-grade-serous-ovarian-cancer-without-inherited-brca1-or-brca2-gene-mutations/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/22/parp-inhibitor-olaparib-has-activity-in-high-grade-serous-ovarian-cancer-without-inherited-brca1-or-brca2-gene-mutations/#comments</comments>
		<pubDate>Mon, 22 Aug 2011 18:39:54 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Clinical Trial Results]]></category>
		<category><![CDATA[Novel Therapies]]></category>
		<category><![CDATA[Pipeline Drugs]]></category>
		<category><![CDATA[AZD2281]]></category>
		<category><![CDATA[BRCA gene mutations]]></category>
		<category><![CDATA[British Columbia Cancer Agency]]></category>
		<category><![CDATA[DNA repair pathway]]></category>
		<category><![CDATA[germline mutations]]></category>
		<category><![CDATA[homologous recombination]]></category>
		<category><![CDATA[Karen A. Gelmon M.D.]]></category>
		<category><![CDATA[Melinda L. Telli M.D.]]></category>
		<category><![CDATA[NYU School of Medicine]]></category>
		<category><![CDATA[Olaparib]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Ovarian Cancer Research Program of BC]]></category>
		<category><![CDATA[PARP inhibitors]]></category>
		<category><![CDATA[poly(ADP-ribose) polymerase]]></category>
		<category><![CDATA[somatic muttations]]></category>
		<category><![CDATA[Stanford University]]></category>
		<category><![CDATA[Stephanie V. Blank M.D.]]></category>
		<category><![CDATA[The Cancer Genome Atlas]]></category>
		<category><![CDATA[The Lancet Oncology]]></category>
		<category><![CDATA[triple negative breast cancer]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7310</guid>
		<description><![CDATA[Researchers affiliated with the British Columbia Cancer Agency reported Phase 2 clinical study results indicating that advanced ovarian cancer, with and without germline (inherited) BRCA 1 or BRCA 2 gene mutations, responded to treatment with the PARP inhibitor olaparib. The Phase 2 study results were published online in the August 21 edition of The Lancet [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7310&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/22/parp-inhibitor-olaparib-has-activity-in-high-grade-serous-ovarian-cancer-without-inherited-brca1-or-brca2-gene-mutations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/gelmon-karen1-0.jpg?w=267" medium="image">
			<media:title type="html">Dr. Karen Gelmon</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/telli-melinda.jpg?w=199" medium="image">
			<media:title type="html">Melinda Telli M.D.</media:title>
		</media:content>
	</item>
		<item>
		<title>U.K. Researchers Launch Clinical Trial of Mercaptopurine (6-MP) In Women with Hereditary Breast and Ovarian Cancer</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/18/u-k-researchers-launch-clinical-trial-of-mercaptopurine-6-mp-in-women-with-hereditary-breast-and-ovarian-cancer/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/18/u-k-researchers-launch-clinical-trial-of-mercaptopurine-6-mp-in-women-with-hereditary-breast-and-ovarian-cancer/#comments</comments>
		<pubDate>Thu, 18 Aug 2011 21:07:56 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Genetic Testing]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[6MP]]></category>
		<category><![CDATA[BRCA gene mutations]]></category>
		<category><![CDATA[Cancer Research UK]]></category>
		<category><![CDATA[DNA damage]]></category>
		<category><![CDATA[Dr. Sally Burtles]]></category>
		<category><![CDATA[hereditary breast & ovarian cancer syndrome]]></category>
		<category><![CDATA[mercaptopurine]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Oxford Biomedical Research Centre]]></category>
		<category><![CDATA[Oxford Experimental Cancer Med. Centre]]></category>
		<category><![CDATA[PARP inhibitors]]></category>
		<category><![CDATA[Prof. Mark Middleton]]></category>
		<category><![CDATA[Purinethol]]></category>
		<category><![CDATA[Shibani Nicum]]></category>
		<category><![CDATA[Suzanne Cole]]></category>
		<category><![CDATA[thiopurines]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7275</guid>
		<description><![CDATA[A Cancer Research UK-funded clinical trial of a new drug for patients with advanced breast or ovarian cancer due to inherited BRCA gene mutations has been launched at the Experimental Cancer Medicine Centre at the University of Oxford. A Cancer Research UK-funded trial of a new drug for patients with advanced breast or ovarian cancer [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7275&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/18/u-k-researchers-launch-clinical-trial-of-mercaptopurine-6-mp-in-women-with-hereditary-breast-and-ovarian-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/dnarepair.jpg?w=233" medium="image">
			<media:title type="html">DNA repair</media:title>
		</media:content>
	</item>
		<item>
		<title>Mesothelin Antibodies Occur In Some Women With An Epidemiologic Risk For Ovarian Cancer.</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/18/mesothelin-antibodies-occur-in-some-women-with-an-epidemiologic-risk-for-ovarian-cancer/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/18/mesothelin-antibodies-occur-in-some-women-with-an-epidemiologic-risk-for-ovarian-cancer/#comments</comments>
		<pubDate>Thu, 18 Aug 2011 16:32:48 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Biomarker]]></category>
		<category><![CDATA[Early Detection]]></category>
		<category><![CDATA[Fertility]]></category>
		<category><![CDATA[Medical Study Results]]></category>
		<category><![CDATA[biomarker]]></category>
		<category><![CDATA[Cancer Epidemiology Biomarkers & Prevention]]></category>
		<category><![CDATA[infertility]]></category>
		<category><![CDATA[Judith Luborsky Ph.D.]]></category>
		<category><![CDATA[mesothelin]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Rush Health]]></category>
		<category><![CDATA[Rush Oak Park Hospital]]></category>
		<category><![CDATA[Rush University]]></category>
		<category><![CDATA[Rush University Medical Center]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7271</guid>
		<description><![CDATA[Researchers at Rush University Medical Center discover mesothelin antibodies in the bloodstream of infertile women, who possess a higher risk of ovarian cancer. Using a new approach to developing biomarkers for the very early detection of ovarian cancer, researchers at Rush University Medical Center have identified a molecule in the bloodstream of infertile women, who [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7271&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/18/mesothelin-antibodies-occur-in-some-women-with-an-epidemiologic-risk-for-ovarian-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/luborsky-judy.jpg" medium="image">
			<media:title type="html">Judy Luborsky, Ph.D.</media:title>
		</media:content>
	</item>
		<item>
		<title>Penn&#8217;s Genetically Modified T Cells Create Antitumor Effect In Mice With Folate Positive Ovarian Cancer; Clinical Trial Pending</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/17/penns-genetically-modified-t-cells-create-antitumor-effect-in-mice-with-folate-positive-ovarian-cancer-clinical-trial-pending/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/17/penns-genetically-modified-t-cells-create-antitumor-effect-in-mice-with-folate-positive-ovarian-cancer-clinical-trial-pending/#comments</comments>
		<pubDate>Wed, 17 Aug 2011 22:50:23 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Gene Therapies]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[Medical Study Results]]></category>
		<category><![CDATA[alpha-folate receptor]]></category>
		<category><![CDATA[CD137 protein]]></category>
		<category><![CDATA[chimeric antigen receptor]]></category>
		<category><![CDATA[Daniel J. Powell Jr. Ph.D.]]></category>
		<category><![CDATA[folic acid]]></category>
		<category><![CDATA[George Coukos M.D. Ph.D.]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Ovarian Cancer Research Center]]></category>
		<category><![CDATA[T cells]]></category>
		<category><![CDATA[Univ of Penn Perelman School of Med]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7253</guid>
		<description><![CDATA[In a recent issue of Cancer Research, researchers from the University of Pennsylvania showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice. A clinical trial involving the modified T cells is expected to be announced within the next few months. In a recent issue of Cancer Research, Daniel [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7253&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/17/penns-genetically-modified-t-cells-create-antitumor-effect-in-mice-with-folate-positive-ovarian-cancer-clinical-trial-pending/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/powell-daniel.jpg" medium="image">
			<media:title type="html">Daniel Powell M.D., Ph.D.</media:title>
		</media:content>
	</item>
		<item>
		<title>Advanced MRI Scan May Predict Chemotherapy Benefit In Late Stage Ovarian Cancer Patients After Just One Cycle</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/16/advanced-mri-scan-may-predict-chemotherapy-benefit-in-late-stage-ovarian-cancer-patients-after-just-one-cycle/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/16/advanced-mri-scan-may-predict-chemotherapy-benefit-in-late-stage-ovarian-cancer-patients-after-just-one-cycle/#comments</comments>
		<pubDate>Tue, 16 Aug 2011 19:34:49 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Medical Study Results]]></category>
		<category><![CDATA[Radiology]]></category>
		<category><![CDATA[apparent diffusion coefficient]]></category>
		<category><![CDATA[Cancer Research UK]]></category>
		<category><![CDATA[diffusion-weighted MRI]]></category>
		<category><![CDATA[Engineering & Physical Res Council]]></category>
		<category><![CDATA[Institute of Cancer Research]]></category>
		<category><![CDATA[Julie Sharp]]></category>
		<category><![CDATA[Marie Curie Actions]]></category>
		<category><![CDATA[MRI]]></category>
		<category><![CDATA[Nandita de Souza]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Stavroula Kyriazi]]></category>
		<category><![CDATA[The Royal Marsden NHS Foundation Trust]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7204</guid>
		<description><![CDATA[Scientists at The Institute of Cancer Research and The Royal Marsden Hospital have developed an advanced type of magnetic resonance imaging (MRI) scan that can detect whether late-stage ovarian cancers are responding to chemotherapy treatment after just one cycle. Scientists at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital have developed an [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7204&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/16/advanced-mri-scan-may-predict-chemotherapy-benefit-in-late-stage-ovarian-cancer-patients-after-just-one-cycle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/diffusionmri.gif" medium="image">
			<media:title type="html">Diffusion MRI</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/desouza.jpg" medium="image">
			<media:title type="html">Professor Nandita deSouza</media:title>
		</media:content>
	</item>
		<item>
		<title>Ovarian Cancer Awareness Through Social Media Technology &#8212;  Are You Ready?</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/14/ovarian-cancer-awareness-through-social-media-technology-are-you-ready/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/14/ovarian-cancer-awareness-through-social-media-technology-are-you-ready/#comments</comments>
		<pubDate>Sun, 14 Aug 2011 23:08:09 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[WORD of HOPE]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[social media technology]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=6468</guid>
		<description><![CDATA[The median age of a women at the time of initial ovarian cancer diagnosis is 63.  How important is social media technology to ovarian cancer awareness? Let us know what you think. The median age of a women at the time of initial ovarian cancer diagnosis is 63. In light of that fact, we are [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=6468&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/14/ovarian-cancer-awareness-through-social-media-technology-are-you-ready/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>

		<media:content url="http://healthinfoispower.files.wordpress.com/2011/08/technology-frustration.jpg?w=300" medium="image">
			<media:title type="html">technology-frustration</media:title>
		</media:content>
	</item>
		<item>
		<title>FDA Approves Clinical Protocol for Additional Phase 1 Study of TKM-PLK1 in Primary Liver Cancer or Liver Metastases</title>
		<link>http://healthinfoispower.wordpress.com/2011/08/12/fda-approves-clinical-protocol-for-additional-phase-1-study-of-tkm-plk1-in-primary-liver-cancer-or-liver-metastases/</link>
		<comments>http://healthinfoispower.wordpress.com/2011/08/12/fda-approves-clinical-protocol-for-additional-phase-1-study-of-tkm-plk1-in-primary-liver-cancer-or-liver-metastases/#comments</comments>
		<pubDate>Fri, 12 Aug 2011 19:03:27 +0000</pubDate>
		<dc:creator>Paul Cacciatore</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Gene Therapies]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Novel Therapies]]></category>
		<category><![CDATA[Pipeline Drugs]]></category>
		<category><![CDATA[2006 Nobel Prize]]></category>
		<category><![CDATA[Andrew Fire Ph.D.]]></category>
		<category><![CDATA[Craig C. Mello Ph.D.]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[lipid nanoparticles]]></category>
		<category><![CDATA[liver cancer]]></category>
		<category><![CDATA[liver metastases]]></category>
		<category><![CDATA[Mark J. Murray]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[National Institutes of Health]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Phase I clinical trials]]></category>
		<category><![CDATA[RNA interference]]></category>
		<category><![CDATA[small interfering RNA]]></category>
		<category><![CDATA[Tekmira Pharma]]></category>
		<category><![CDATA[TKM-PLK1]]></category>

		<guid isPermaLink="false">http://healthinfoispower.wordpress.com/?p=7127</guid>
		<description><![CDATA[The U.S. Food and Drug Administration approves the clinical protocol for an additional Phase 1 study of TKM-PLK1 in patients with either primary liver cancer or liver metastases associated with select cancers including ovarian. RNA Interference Nucleic acids are molecules that carry genetic information and include DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). Together these [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=healthinfoispower.wordpress.com&amp;blog=3013851&amp;post=7127&amp;subd=healthinfoispower&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://healthinfoispower.wordpress.com/2011/08/12/fda-approves-clinical-protocol-for-additional-phase-1-study-of-tkm-plk1-in-primary-liver-cancer-or-liver-metastases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/b0ebfd3d89f30da315e588fc8a1a0a06?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">paulc</media:title>
		</media:content>
	</item>
	</channel>
</rss>
